Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and ...

Ozempic was launched in India on Friday (December 12). The blockbuster drug by Novo Nordisk will be marketed for adults with type-2 diabetes, unlike in the US and Europe where it is also sold as ...

Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...

The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering. The Japan Insulin Pen Market is forecasted to rise from US$ 304.26 Million in 2024 to US$ ...